ICS Global Limited, an investment holding company, provides medical billing services in Australia and the United Kingdom.
Flawless balance sheet with outstanding track record.
Share Price & News
How has ICS Global's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ICS has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ICS exceeded the Australian Healthcare industry which returned -1.5% over the past year.
Return vs Market: ICS exceeded the Australian Market which returned -10.3% over the past year.
Price Volatility Vs. Market
How volatile is ICS Global's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StHere's What ICS Global Limited's (ASX:ICS) ROCE Can Tell Us
1 month ago | Simply Wall StHow Much Of ICS Global Limited (ASX:ICS) Do Insiders Own?
2 months ago | Simply Wall StICS Global (ASX:ICS) Shareholders Booked A 64% Gain In The Last Year
Is ICS Global undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ICS (A$1.96) is trading below our estimate of fair value (A$46.18)
Significantly Below Fair Value: ICS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ICS is poor value based on its PE Ratio (14.5x) compared to the Healthcare industry average (13.5x).
PE vs Market: ICS is good value based on its PE Ratio (14.5x) compared to the Australian market (16x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ICS's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ICS is overvalued based on its PB Ratio (3.2x) compared to the AU Healthcare industry average (1.4x).
How is ICS Global forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ICS Global has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether ICS Global is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- ICS Global competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has ICS Global performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ICS has high quality earnings.
Growing Profit Margin: ICS's current net profit margins (22.5%) are higher than last year (16%).
Past Earnings Growth Analysis
Earnings Trend: ICS's earnings have grown by 4.7% per year over the past 5 years.
Accelerating Growth: ICS's earnings growth over the past year (66.6%) exceeds its 5-year average (4.7% per year).
Earnings vs Industry: ICS earnings growth over the past year (66.6%) exceeded the Healthcare industry 4.3%.
Return on Equity
High ROE: ICS's Return on Equity (22.1%) is considered high.
How is ICS Global's financial position?
Financial Position Analysis
Short Term Liabilities: ICS's short term assets (A$5.8M) exceed its short term liabilities (A$3.4M).
Long Term Liabilities: ICS's short term assets (A$5.8M) exceed its long term liabilities (A$454.7K).
Debt to Equity History and Analysis
Debt Level: ICS is debt free.
Reducing Debt: ICS had no debt 5 years ago.
Debt Coverage: ICS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ICS has no debt, therefore coverage of interest payments is not a concern.
What is ICS Global current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ICS's dividend (3.57%) is higher than the bottom 25% of dividend payers in the Australian market (2.51%).
High Dividend: ICS's dividend (3.57%) is low compared to the top 25% of dividend payers in the Australian market (6.39%).
Stability and Growth of Payments
Stable Dividend: ICS has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: ICS's dividend payments have increased, but the company has only paid a dividend for 8 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (66.7%), ICS's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
ICS Global has no CEO, or we have no data on them.
|Executive Chairman & MD of Medical Billing Service||4.83yrs||AU$246.51k||1.65% A$343.0k|
|Company Secretary & Independent Non-Executive Director||10.25yrs||AU$56.07k||2.91% A$605.7k|
|Independent Non-Executive Chairman||10yrs||AU$74.07k||5.05% A$1.0m|
|Independent Non-Executive Director||10yrs||AU$38.07k||2.96% A$615.2k|
|Independent Non-Executive Director||9.92yrs||AU$56.07k||0.47% A$98.0k|
Experienced Board: ICS's board of directors are seasoned and experienced ( 10 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
ICS Global Limited's company bio, employee growth, exchange listings and data sources
- Name: ICS Global Limited
- Ticker: ICS
- Exchange: ASX
- Founded: 1999
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: AU$20.784m
- Shares outstanding: 10.60m
- Website: https://icsglobal.com.au
- ICS Global Limited
- 20 Bond Street
- Suite 3.03
- New South Wales
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ICS||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Dec 1999|
|ICS||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Dec 1999|
ICS Global Limited, an investment holding company, provides medical billing services in Australia and the United Kingdom. The company offers medical billing and collection services to medical consultants and specialists. ICS Global Limited was founded in 1999 and is based in Sydney, Australia.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/07/08 10:37|
|End of Day Share Price||2020/07/08 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.